A randomized trial to assess the safety and tolerability of taribavirin vs. ribavirin in combination with pegylated interferon alfa in management of HCV/HIV coinfected subjects
Who Can Enroll: HIV-HepC co-infection.
Study Therapy: Taribavirin vs Ribavirin with pegylated interferon alfa.
A5269
The Efficacy and Safety of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Naive Genotype 1 Subjects with HIV infection
Who Can Enroll: HIV-HepC co-infection with no prior HCV treatment.
Study Therapy: Nitazoxanide plus Peginterferon Alfa-2a + Ribavirin.
